Alberto Fernández’s Post

◆I'm thrilled that i just completed Pfizer UK's Molecule to Market on Forage . In the simulation I: • Completed a job simulation focused on launching a hypothetical new medicine. • Identified the clinical care pathway and prepared evidence to submit to NICE •Created a brand positioning statement and presented a pitch for the new medicine. • Researched the needs of specific patient and customer types and created an effective go-to-market strategy.💊

Take a sneak peek inside the Schnellmann Lab as Dean Schnellmann and Chris Edwards, associate clinical professor, talk research and the future. This episode features discussions on the trials of drug discovery, the versatility of pharmacy careers, and the growth of the Phoenix campus. https://lnkd.in/gsHT4waJ #UAZPharmacy

I just completed Pfizer UK's Molecule to Market on @[Forage](urn:li:organization:68514998). In the simulation I:  * Completed a job simulation focused on launching a hypothetical new medicine.  * Identified the clinical care pathway and prepared evidence to submit to NICE.  * Created a brand positioning statement and presented a pitch for the new   medicine.   * Researched the needs of specific patient and customer types and created an   effective go-to-market strategy.

I just completed Pfizer UK's Molecule to Market on @[Forage]. In the simulation I: *Completed a job simulation focused on launching a hypothetical new medicine. *Identified the clinical care pathway and prepared evidence to submit to NICE. *Created a brand positioning statement and presented a pitch for the new medicine.  *Researched the needs of specific patient and customer types and created an effective go-to-market strategy.

Last week marked significant leadership changes in the Biopharma industry: Gilead Sciences: Chief Medical Officer Merdad Parsey to depart early next year. Engitix: Matt Edwards joins as SVP, Discovery; Bevan Emma Huang as VP, Data Sciences. Rectify Pharmaceuticals: Bharat Reddy becomes Chief Business Officer. AffyImmune: Daniel Janse takes the helm as CEO and President. Nkarta: Nadir Mahmood promoted to President; David Shook named Chief Medical Officer and Head of R&D. SFA Therapeutics: James Kirwin steps in as COO. Optibrium: James Halle appointed Chief Commercial Officer. Ophirex: Jeremy Gowler takes over as CEO. Mogrify: Jonathan Appleby joins as Chief Scientific Officer. Sydnexis: Perry Steinberg appointed CEO. BeiGene: Aaron Rosenberg, CFA becomes CFO. AbTherx: Pallavi Tawde to lead Preclinical R&D Strategy. Velocity Clinical Research: Mike Zaranek joins as CFO. Avalo Therapeutics: Mittie Doyle appointed CMO. HAYA Therapeutics: Eric Adam becomes COO. Oxford Biomedica: Lucinda Crabtree, PhD takes on CFO role. MMS: Ben Dudley appointed Chief Commercial Officer. Serina Therapeutics: Srini Tenjarla joins as SVP of CMC and Formulation. Alkeus Pharmaceuticals: Tamara Dillon becomes Chief Human Resources Officer. Nouscom: Tiffany Muller promoted to CFO; Loredana Siani to SVP, Technical and CMC Development. PepGen: Afsaneh Mohebbi, PhD joins as SVP, Portfolio and Program Management; Dave Borah, CFA as SVP, Investor Relations and Corporate Communications. It will be interesting to see how these new leaders shape their organizations' futures. If you found this helpful, consider resharing ♻️ and follow for more industry updates.

I just completed Pfizer UK's Molecule to Market on Forage. In the simulation I: * Completed a job simulation focused on launching a hypothetical new medicine. * Identified the clinical care pathway and prepared evidence to submit to NICE. * Created a brand positioning statement and presented a pitch for the new medicine.  * Researched the needs of specific patient and customer types and created an effective go-to-market strategy.

🎤 Speaker Spotlight: David Vincent, CEO/ B.Sc., MPH, PhD🎤 We’re thrilled to announce, David Vincent, CEO/ B.Sc., MPH, PhD, Chief Scientific Officer (CSO) at VTI Life Sciences, as a featured speaker at the Cleaning Validation 2025 event! 🌟 Join us in January! https://lnkd.in/gqgdqd2n #CleaningValidation #CleaningValidation2025 #PharmaceuticalInnovation #PharmaEd #QualityAssurance #CleaningProtocols #ValidationTesting #PharmaQuality #ProcessValidation

I just completed Pfizer UK's Molecule to Market on Forage. In the simulation I: Completed a job simulation focused on launching a hypothetical new medicine. Identified the clinical care pathway and prepared evidence to submit to NICE. Created a brand positioning statement and presented a pitch for the new medicine.  Researched the needs of specific patient and customer types and created an effective go-to-market strategy. Check out the simulation here: https://lnkd.in/e3fPJmn5

I just completed Pfizer UK's Molecule to Market on Forage. In the simulation I: Completed a job simulation focused on launching a hypothetical new medicine. Identified the clinical care pathway and prepared evidence to submit to NICE. Created a brand positioning statement and presented a pitch for the new medicine.  Researched the needs of specific patient and customer types and created an effective go-to-market strategy. Check out the simulation here: https://lnkd.in/d8znxcn4